Cambridge, Massachusetts-based biotech Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors for the ...
Sino-American biotech Regor Pharmaceuticals has entered into a definitive purchase agreement whereby Swiss pharma major Roche ...
The Swiss pharma is paying Regor Therapeutics $850 million to buy a pair of prospects it sees as potential successors to ...
Genentech to buy Regor's portfolio of next-generation CDK inhibitors to treat breast cancer: Cambridge, Massachusetts Tuesday, October 1, 2024, 10:00 Hrs [IST] Regor Pharmaceutica ...
As has been widely acknowledged, one of the most meaningful steps a business can take is to establish a single point of ...
Roche focuses on obesity drug development, fast-tracking its CT-388 candidate, and targeting $3.6 billion in annual sales.
US RNAi therapeutics company Alnylam Pharmaceuticals has released two new data sets from the HELIOS-B Phase III study of ...
The man charged with attempting to assassinate Donald Trump after allegedly positioning himself with a rifle outside one of the former president's Florida golf courses on Sept. 15 pleaded not ...
A trader works on the trading floor at The New York Stock Exchange (NYSE), in New York City, U.S., September 18, 2024. REUTERS/Andrew Kelly/File Photo The S&P 500 sputtered to a record high close ...
Copyright 2024 The Associated Press. All Rights Reserved. People across the American Southeast stay resilient in the wake of Hurricane Helene Americans in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback